Price $2.81 |
Market Cap
403.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
0.03
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
364K
|
FCF
-1.9
|
|
Op. Margin
-12.60%
|
Net Margin
-16.20%
|
ROE
747.40%
|
ROI
-10.90%
|
|
ROA
-12.70%
|
EPS Growth
-252.50%
|
Current Ratio
1.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| RTI Surgical Inc (RTIX) | $4.74 | - | - | 288.4M | Strong Buy |
| Hologic, Inc. (HOLX) | $41.27 | - | - | 11.17B | Strong Buy |
| American Renal Associates Hold (ARA) | $19.48 | - | - | 702.9M | Strong Buy |
| Imprimis Pharmaceuticals Inc (IMMY) | $3.48 | - | - | 58.7M | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.24 | - | - | 65M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
